Failure to receive this treatment can lead to a serious risk of anemia in some patients, leading to hospitalization, transfusion and life-threatening conditions.
“This vitamin contributes to the proper functioning of the brain and nervous system. A deficiency causes fatigue, nausea, digestive problems, numbness and memory loss.” Marie-Laure André, dietician-nutritionist, reminded us recently. The problem is this famous vitamin “is currently experiencing severe supply tension due to a production shutdown and manufacturing difficulties” announced the Medicines Agency in a press release on September 19. “A return to normal supply is not expected before November 2024.”
This vitamin is called “cyanocobalamin” or more commonly “vitamin B12”. The Zentiva and Substipharm laboratories that market it in injectable and drinkable solution are facing supply difficulties. Vitamin B12 in injectable and drinkable solution is used by intramuscular injection in the treatment of deficiencies due to a gastrointestinal disease that prevents its absorption (in particular Biermer’s disease, total gastrectomy, resection of the terminal ileum, Imerslund’s disease). Orally, it is indicated in the treatment of deficiencies due to lack of dietary intake, particularly in strict vegan diets.
“We recommend that vitamin B12 tablets be given priority whenever possible. This will allow patients who require intramuscular injections of vitamin B12 to continue their treatment. Failure to receive this treatment can put these patients at serious risk of anemia, leading to hospitalization, transfusion and life-threatening outcomes.” informs theANSMThe agency also asked laboratories to stagger supplies to city pharmacies in order to avoid stock shortages. Supplies to health establishments are maintained.
If you usually take vitamin B12 ampoules orally (by drinking them), you should use the tablets instead, until the supply returns to normal. To adjust the dose and frequency of taking, contact your doctor or ask your pharmacist for advice.